The European Commission put the current text of EU-GMP Annex 7 into operation on 1 September 2009. It still sets the documentation test a Canadian cannabis flower batch has to pass before an EU importer's Qualified Person (QP) will sign for it.
EU-GMP Annex 7 is the part of the EU-GMP guide that governs herbal starting materials. For a Licensed Producer (LP) operating under a Health Canada licence, it defines the specification file, storage conditions, foreign-matter checks and sampling controls that European importers expect behind every flower batch. Cultivation itself falls under Good Agricultural and Collection Practice (GACP).
Most Canadian LPs already hold the underlying data. Where they lose weeks is presenting it in the order Annex 7 asks for it.
What EU-GMP Annex 7 covers for cannabis flower
Annex 7 applies to all herbal starting materials: medicinal plants, herbal substances and herbal preparations. In EU terminology, a herbal substance is what the European Pharmacopoeia (Ph. Eur.) calls a herbal drug. Dried cannabis flower fits that definition, which is why Annex 7 and the Ph. Eur. cannabis flower monograph tend to show up in the same audit.
Where GACP ends and GMP begins
The annex carries a reference table that splits herbal production across three standards. Cultivation, collection and harvesting sit under GACP. Cutting and drying sit at the handover: steps done in the field follow GACP where the marketing authorisation justifies it, and GMP applies to further cutting and drying. Extraction and later processing fall under Part II of the GMP guide, and processing into a dosage form falls under Part I.
The explanatory note under that table is the line most LPs skim past. The GMP classification of herbal material depends on how the manufacturing authorisation holder uses it, so the same flower can be treated as an active substance, an intermediate or a finished product. Your importer makes that classification, and your file has to support it.
Why the boundary moved in 2025 and 2026
The European Medicines Agency's Committee on Herbal Medicinal Products adopted Revision 1 of the GACP guideline on 9 July 2025, its first major rewrite since 2006 and the first to deal directly with indoor cultivation. Eleven months later, German state inspectors in Hesse were applying a narrow reading of the drying and decontamination boundary, as we set out in our analysis of Germany's GMP-washing crackdown. The annex text is the same as in 2009, but German inspectors now apply it more strictly at the drying stage.
The Annex 7 specification file: 14 items EU importers check
Clause 8 of Annex 7 lists what the documentation for a herbal substance has to contain. Read against a cannabis flower batch, it becomes a 14-item file. We call it the Annex 7 specification file, and it's usually the first document an importer's quality team opens during a supplier audit.
| Annex 7 item | What the importer expects for flower | Typical Canadian source |
|---|---|---|
| Botanical name | Cannabis sativa L., cultivar name and chemotype | Cultivar master record |
| Source of the plant | Country, site, harvest date, pesticides used | Cultivation and harvest batch record |
| Plant part used | Dried female inflorescence, trimmed | Product specification |
| Drying system | Method, drying time and temperature | Drying SOP and room logs |
| Description | Macroscopic and microscopic examination | Incoming QC or release record |
| Identification | Identity tests plus a reference specimen | Lab method and retained reference |
| Water content | Determined by a Ph. Eur. method | Batch release test |
| Assay | THC, CBD and marker limits | Accredited lab COA |
| Pesticides | Ph. Eur. or validated method, stated limits | Lab COA and method summary |
| Microbial and mycotoxins | Fungal, microbial, aflatoxin and infestation limits | Lab COA |
| Toxic metals and contaminants | Heavy metals, adulterants, likely contaminants | Lab COA |
| Foreign materials | Test and acceptance limit | Visual inspection record |
| Monograph tests | Any extra tests from the Ph. Eur. monograph | Gap analysis against the monograph |
| Decontamination treatment | Process, tests and residue limits | Treatment SOP and validation data |
Where Canadian files usually fall short
Assay and contaminant data are rarely the problem. The Cannabis Regulations already require lot testing for cannabinoids and contaminants, and many Canadian testing labs hold ISO/IEC 17025 accreditation. The gaps show up in three items: drying system, description and decontamination treatment.
A drying SOP that only says "dry until ready" won't meet the drying system item. Annex 7 wants drying time and temperature written into the processing instructions, and an auditor will compare those parameters against your room logs. Our guide to drying and curing standards for export flower sets out the parameters to document. Microscopic examination is the second gap, because it isn't part of the standard Canadian release panel and has to be requested separately.
The third gap is decontamination. Annex 7 requires any treatment used to reduce microbial contamination to be documented with process details, tests and residue limits. That applies to irradiated cannabis flower as much as to any other method. Close those three items first, because the other eleven are usually sitting in your batch records already.
Storage, processing and foreign-matter controls
Storage areas
Clauses 1 to 4 set four storage expectations for herbal substances:
- Separate storage areas, protected against insects and rodents
- Different enclosed areas for quarantined and approved material
- Good aeration, with containers placed so air can circulate
- Humidity, temperature and light conditions provided and monitored where the material needs them
For flower, the last point carries the most weight. Water activity drifts when humidity control slips, and terpene loss speeds up with heat. Auditors will want the monitoring records behind those conditions.
Production areas and dust
Clause 5 asks for specific provisions wherever sampling, weighing, mixing or processing generates dust, such as dust extraction or dedicated premises. In a cannabis facility, that means trim rooms and packaging lines. If two cultivars run through the same packaging room on the same day, expect a question about cross-contamination controls.
Container-by-container inspection
Clause 10 is the one Canadian LPs underestimate. It requires written instructions and records showing that each container of herbal substance is examined for adulteration, substitution and foreign matter, including metal or glass, animal parts or excrement, stones, sand, rot and signs of decay. The requirement covers every container in the batch.
Hand-trimmed flower starts with an advantage here, since a trimmer has already handled every bud before it reaches the container. That advantage only counts if the trim room records the inspection, so add a per-container sign-off to the trim record.
Sampling, reference samples and QC expertise
Annex 7 treats herbal material as heterogeneous by nature. Clause 13 requires sampling by personnel with particular expertise, and each batch has to be identified by its own documentation. Clause 15 extends that expectation to quality control staff, who should be able to recognise adulteration, fungal growth, infestation and non-uniformity within a delivery. A sampling plan for batch testing built only for the Canadian release panel won't always satisfy that wording.
Clause 14 asks for a reference sample of the plant material, especially where the substance isn't described in the European Pharmacopoeia or a Member State pharmacopoeia. Flower now has a Ph. Eur. monograph, but keep one per batch anyway. If a dispute ever reaches the QP batch release decision, that sample is the evidence you'll want.
Our view on readiness
An LP that can't produce a drying-system specification and per-container inspection records shouldn't bid on an EU medical tender yet. Both gaps take months to close properly, because the records have to exist for batches grown before the tender opened.
AlphaLeaf is a Montreal-based Health Canada Licensed Producer of indoor-grown, hand-trimmed cannabis flower from refined genetics. We hold export authorisation under the Cannabis Act and keep ISO/IEC 17025-tested batch data, drying records and full traceability files ready for the review EU importers and their Qualified Persons run against Annex 7.
If you're qualifying a Canadian supplier for the EU medical channel, talk to our export team about the batch documentation behind our flower. Start with the drying records.
Frequently Asked Questions
Does EU-GMP Annex 7 apply to dried cannabis flower?
Yes. Annex 7 covers all herbal starting materials, and dried cannabis flower is a herbal substance in EU terminology. How strictly GMP applies depends on how the importer's manufacturing authorisation holder classifies the material.
Is cannabis drying covered by GACP or GMP under Annex 7?
Annex 7 places cutting and drying at the handover point. Initial steps in the field follow GACP where the marketing authorisation justifies it, and GMP applies to further cutting and drying. German state inspectors read that boundary narrowly in 2026.
What must an Annex 7 specification for cannabis flower include?
Clause 8 requires the botanical name and chemotype, plant source and harvest details, plant part, drying system, macro and microscopic description, identification tests, water content, assay, pesticide limits, microbial and mycotoxin limits, toxic metals and foreign materials. Any decontamination treatment must also be documented.
Does Annex 7 allow irradiation of cannabis flower?
Annex 7 does not prohibit treatments that reduce microbial contamination. It requires them to be documented with process details, tests and residue limits. Whether a treatment is accepted also depends on the importing country's authority and the product authorisation.
Is Health Canada GPP equivalent to EU-GMP Annex 7?
No. Good production practices under the Cannabis Regulations are a Canadian licensing requirement, not an EU GMP standard. EU importers still expect GMP evidence for the relevant steps and an Annex 7 specification file.
Who reviews a Canadian LP's Annex 7 documentation?
The importer's quality unit reviews it during supplier qualification, and the Qualified Person relies on it before certifying a batch for release. Inspectors from the importing country's competent authority can also request it.
